The Ensign Group, Inc. (NASDAQ:ENSG – Get Free Report) Director Barry Smith sold 700 shares of The Ensign Group stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the transaction, the director owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. This represents a 3.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
The Ensign Group Stock Performance
Shares of ENSG stock opened at $164.29 on Friday. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.06. The Ensign Group, Inc. has a 12-month low of $134.79 and a 12-month high of $218.00. The business’s 50 day moving average is $185.49 and its two-hundred day moving average is $187.82. The company has a market capitalization of $9.60 billion, a P/E ratio of 26.76, a P/E/G ratio of 1.64 and a beta of 0.68.
The Ensign Group (NASDAQ:ENSG – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.06. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The business had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same period in the prior year, the company posted $1.52 EPS. The business’s quarterly revenue was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Analysts expect that The Ensign Group, Inc. will post 6.79 EPS for the current fiscal year.
The Ensign Group Announces Dividend
Wall Street Analyst Weigh In
ENSG has been the subject of several research analyst reports. Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a research report on Tuesday, April 21st. Royal Bank Of Canada reiterated an “outperform” rating and issued a $222.00 price objective (up from $206.00) on shares of The Ensign Group in a report on Monday, February 9th. UBS Group set a $230.00 target price on The Ensign Group and gave the company a “buy” rating in a report on Friday, February 6th. Zacks Research downgraded The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Finally, Truist Financial set a $215.00 price target on The Ensign Group and gave the stock a “hold” rating in a research note on Friday, February 6th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $216.75.
Get Our Latest Stock Report on ENSG
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the company. Baillie Gifford & Co. increased its position in The Ensign Group by 62.1% during the fourth quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock worth $795,964,000 after purchasing an additional 1,750,645 shares during the last quarter. Wasatch Advisors LP boosted its holdings in The Ensign Group by 6.0% in the 2nd quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after purchasing an additional 199,983 shares during the last quarter. Capital Research Global Investors grew its stake in shares of The Ensign Group by 7.2% in the 3rd quarter. Capital Research Global Investors now owns 2,016,101 shares of the company’s stock valued at $348,322,000 after buying an additional 136,260 shares during the period. Geode Capital Management LLC grew its stake in shares of The Ensign Group by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company’s stock valued at $261,107,000 after buying an additional 49,117 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of The Ensign Group by 9.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company’s stock worth $232,124,000 after buying an additional 118,110 shares during the last quarter. Institutional investors and hedge funds own 96.12% of the company’s stock.
The Ensign Group Company Profile
The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.
Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.
See Also
- Five stocks we like better than The Ensign Group
- Macy’s Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious
- NVIDIA Sends a Message With RTX Spark—This Is What It Says
- Buy the Dip? Broadcom’s AI Moat Is Wider Than Ever
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.
